Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

1.

Loss of δ-catenin function in severe autism.

Nature.
Turner TN, Sharma K, Oh EC, Liu YP, Collins RL, Sosa MX, Auer DR, Brand H, Sanders SJ, Moreno-De-Luca D, Pihur V, Plona T, Pike K, Soppet DR, Smith MW, Cheung SW, Martin CL, State MW, Talkowski ME, Cook E, Huganir R, Katsanis N, Chakravarti A.
| Mar 25, 2015
2.

Perspective: Special delivery for the gut.

Nature.
Traverso G, Langer R.
| Mar 25, 2015
3.

Harnessing RNA interference for therapy: the silent treatment.

JAMA.
Lieberman J, Sharp PA.
| 3 25, 2015
4.

Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance.

Science.
Yang S, Fujikado N, Kolodin D, Benoist C, Mathis D.
| Mar 19, 2015
5.

A prudent path forward for genomic engineering and germline gene modification.

Science.
Baltimore BD, Berg P, Botchan M, Carroll D, Charo RA, Church G, Corn JE, Daley GQ, Doudna JA, Fenner M, Greely HT, Jinek M, Martin GS, Penhoet E, Puck J, Sternberg SH, Weissman JS, Yamamoto KR.
| Mar 19, 2015
6.

Choosing an antibiotic for skin infections.

N. Engl. J. Med.
Wessels MR.
| Mar 19, 2015
7.

Atomic structure of anthrax protective antigen pore elucidates toxin translocation.

Nature.
Jiang J, Pentelute BL, Collier RJ, Zhou ZH.
| Mar 16, 2015
8.

Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials.

Lancet.
Palmerini T, Benedetto U, Bacchi-Reggiani L, Riva DD, Biondi-Zoccai G, Feres F, Abizaid A, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Genereux P, Bhatt DL, Orlandi C, De Servi S, Petrou M, Rapezzi C, Stone GW.
| Mar 13, 2015
11.

Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switch.

Proc. Natl. Acad. Sci. U.S.A.
Nunes DN, Dias-Neto E, Cardó-Vila M, Edwards JK, Dobroff AS, Giordano RJ, Mandelin J, Brentani HP, Hasselgren C, Yao VJ, Marchiò S, Pereira CA, Passetti F, Calin GA, Sidman RL, Arap W, Pasqualini R.
| Mar 24, 2015
12.

Can BRIGHT Restore the Glow of Bivalirudin?

JAMA.
Cavender MA, Faxon DP.
| Mar 16, 2015
13.

Genetic and functional characterization of clonally derived adult human brown adipocytes.

Nat. Med.
Shinoda K, Luijten IH, Hasegawa Y, Hong H, Sonne SB, Kim M, Xue R, Chondronikola M, Cypess AM, Tseng YH, Nedergaard J, Sidossis LS, Kajimura S.
| Mar 16, 2015
14.

Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease.

N. Engl. J. Med.
Douglas PS, Hoffmann U, Patel MR, Mark DB, Al-Khalidi HR, Cavanaugh B, Cole J, Dolor RJ, Fordyce CB, Huang M, Khan MA, Kosinski AS, Krucoff MW, Malhotra V, Picard MH, Udelson JE, Velazquez EJ, Yow E, Cooper LS, Lee KL.
| Mar 14, 2015
15.

Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events.

N. Engl. J. Med.
Sabatine MS, Giugliano RP, Wiviott SD, Raal FJ, Blom DJ, Robinson J, Ballantyne CM, Somaratne R, Legg J, Wasserman SM, Scott R, Koren MJ, Stein EA.
| Mar 15, 2015
16.

Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction.

N. Engl. J. Med.
Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Ophuis TO, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS.
| Mar 14, 2015
17.

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial.

Lancet.
Ruff CT, Giugliano RP, Braunwald E, Morrow DA, Murphy SA, Kuder JF, Deenadayalu N, Jarolim P, Betcher J, Shi M, Brown K, Patel I, Mercuri M, Antman EM.
| Mar 10, 2015
19.

Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial.

Lancet.
Mega JL, Walker JR, Ruff CT, Vandell AG, Nordio F, Deenadayalu N, Murphy SA, Lee J, Mercuri MF, Giugliano RP, Antman EM, Braunwald E, Sabatine MS.
| Mar 10, 2015